TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect ...

Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

AI can do more than just write your essays - a new model is advancing drug discovery for hard-to-treat diseases.

Ascension became the first provider in Wisconsin to administer Kisunla, a new FDA-approved drug for Alzheimer’s, which is ...

As breakthrough medications are beginning to slow the progression of Alzheimer’s disease, innovations such as virtual reality ...

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance ...

A NEW digital Alzheimer’s test could make the “biggest difference” to diagnoses. The test can be performed by patients on ...

Almost one in four healthcare staff working in NHS dementia services believe they are unable to provide patients with the ...

Compared to traditional imaging options for Alzheimer’s diagnosis, including PET scans, QSM MRI is “non-invasive and much ...

Protein discovery may lead to Alzheimer’s treatment even before symptoms start - Researchers hope findings could help delay ...

Research reveals biological differences in lipids between sexes as two-thirds of Americans with Alzheimer's disease are women, study suggests dietary changes.

GADSDEN, Ala. - Alabama Cancer Care has opened a new, state-of-the-art Alzheimer's care and support facility in Etowah County ...